Phase II randomized, multicenter, crossover clinical trial for administration of exemestane vs. anastrozole as first line treatment for postmenopausal patients with hormone receptor positive advanced breast cancer

Trial Profile

Phase II randomized, multicenter, crossover clinical trial for administration of exemestane vs. anastrozole as first line treatment for postmenopausal patients with hormone receptor positive advanced breast cancer

Completed
Phase of Trial: Phase II

Latest Information Update: 29 Jun 2011

At a glance

  • Drugs Anastrozole; Exemestane
  • Indications Advanced breast cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Jun 2011 Results published in the Cancer.
    • 24 Sep 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 11 Feb 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top